Effect of Polydeoxyribonucleotide on Chondrocutaneous Composite Grafts Survival
- 96 Downloads
A composite graft is considered the best choice for facial reconstruction because of proper texture, color, and simple surgical techniques. However, due to revascularization by the bridging phenomenon, it has limitations with unpredictable survival rates and can be applied only to small defects. Polydeoxyribonucleotide (PDRN) plays an important role in multiple vascular processes such as angiogenesis via production of a vascular endothelial growth factor and by providing an anti-inflammatory effect by reducing pro-inflammatory cytokines through the adenosine A2 receptor stimulation. Thus, here, we investigated PDRN as a supportive method to improve survival of composite grafts.
Chondrocutaneous composite grafts were applied to both ears of 20 New Zealand White rabbits. The grafts were then rotated and returned to their positions to prevent the original blood flow from the base of the grafts. On postoperative days 1, 3, 6, 9, and 12, PDRN was injected intradermally into the experimental group (20 ears) and normal saline was injected into the control group (20 ears) to exclude bias of pressure effect. After 12 days, graft survival and cutaneous blood flow were examined under laser speckle contrast imaging.
Gross observation indicated that the graft viability in the PDRN group was significantly higher than that in the control group (p < 0.05). Through laser speckle contrast imaging, signal intensity increased from the periphery and progressed centrally with treatment.
Our findings suggest that PDRN may increase blood flow around at the base of the graft, restore the perfusion, and improve the survival of the composite grafts.
No Level Assigned
This journal requires that authors assign a level of evidence to each article. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authors www.springer.com/00266.
KeywordsPolydeoxyribonucleotides Tissue transplantation Graft survival
This work was supported (in part) by the Yonsei University miraeseondo project of 2017 (2017-52-0064).
Compliance with Ethical Standards
Conflict of interest
The authors declare that they have no conflicts of interest.
Human and Animal Rights
The Animal Care and Experiment Committee of Yonsei Wonju University approved the experimental protocol.
For this type of study, informed consent is not required.
- 1.Hong JP (2018) Flap classification and applications. In: Neligan PC (ed) Plastic surgery, 4th edn. Elsevier Saunders, Philadelphia, pp 336–432Google Scholar
- 2.Scherer SS, Pietramaggiori G, Orgill DP (2018) Skin graft. In: Neligan PC (ed) Plastic surgery, 4th edn. Elsevier Saunders, Philadelphia, pp 214–230Google Scholar
- 20.Bitto A, Polito F, Irrera N, D’Ascola A, Avenoso A, Nastasi G, Campo GM, Micali A, Bagnato G, Minutoli L, Marini H, Rinaldi M, Squadrito F, Altavilla D (2011) Polydeoxyribonucleotide reduces cytokine production and the severity of collagen-induced arthritis by stimulation of adenosine A(2A) receptor. Arthritis Rheum 63:3364–3371CrossRefGoogle Scholar
- 22.Hwang KH, Kim JH, Park EY, Cha SK (2018) An effective range of polydeoxyribonucleotides is critical for wound healing quality. Mol Med Rep 18:5166–5172Google Scholar
- 26.De Aloe G, Rubegni P, Biagioli M, Taddeucci P, Fimiani M (2004) Skin graft donor site and use of polydeoxyribonucleotide as a treatment for skin regeneration: a randomized, controlled, double-blind, clinical trial. Wounds 16:258–263Google Scholar
- 32.Lazzarotto M, Tomasello EM, Caporossi A (2004) Clinical evaluation of corneal epithelialization after photorefractive keratectomy in a patients treated with polydeoxyribonucleotide (PDRN) eye drops: a randomized, double-blind, placebo-controlled trial. Eur J Ophthalmol 14:284–289CrossRefGoogle Scholar